Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Invasive Technique vs Opioids for Cancer Pain
NCT05594459Unknown
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- Nov 2022
- Primary completion
- Jul 2024
01
Overview
Randomised, open-label trial (2 arms), sponsored by IRCCS Regina Elena National Cancer Institute. Primary endpoint: European Organization for Research and Treatment of Cancer Quality of life-Core 30 Summary Score at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT05594459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594459.